The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Hetero Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
10 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VIRATERO tenofovir disoproxil fumarate 300mg tablets blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HETENOFOVIR tenofovir disoproxil fumarate 300mg tablets bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HETEVIR tenofovir disoproxil fumarate 300mg tablets blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TEROVIR tenofovir disoproxil fumarate 300mg tablets blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HETEVIR tenofovir disoproxil fumarate 300mg tablets bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TENOFOVIR HETERO tenofovir disoproxil fumarate 300mg tablets blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TENOFOVIR HETERO tenofovir disoproxil fumarate 300mg tablets bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for HETENOFOVIR tenofovir disoproxil fumarate 300mg tablets blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TEROVIR tenofovir disoproxil fumarate 300mg tablets bottle.
-
Prescription medicine registrationActive ingredients: Tenofovir disoproxil fumarate.